Pharming Group (PHAR)
9.80
-0.65
(-6.22%)
USD |
NASDAQ |
May 02, 13:45
Pharming Group Free Cash Flow (Quarterly): 11.25M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.25M |
| September 30, 2023 | 3.38M |
| June 30, 2023 | -10.39M |
| March 31, 2023 | -23.00M |
| December 31, 2022 | 4.92M |
| September 30, 2022 | 12.51M |
| June 30, 2022 | 2.815M |
| March 31, 2022 | 0.234M |
| December 31, 2021 | 9.805M |
| September 30, 2021 | 2.628M |
| June 30, 2021 | 4.595M |
| March 31, 2021 | 4.098M |
| December 31, 2020 | 15.29M |
| September 30, 2020 | 17.68M |
| June 30, 2020 | 20.55M |
| March 31, 2020 | 14.80M |
| December 31, 2019 | 19.16M |
| September 30, 2019 | 3.599M |
| June 30, 2019 | 15.30M |
| March 31, 2019 | 10.63M |
| December 31, 2018 | 16.30M |
| September 30, 2018 | 17.00M |
| June 30, 2018 | 10.99M |
| March 31, 2018 | -2.257M |
| December 31, 2017 | 32.47M |
| Date | Value |
|---|---|
| September 30, 2017 | 13.27M |
| June 30, 2017 | -0.9876M |
| March 31, 2017 | -6.156M |
| December 31, 2016 | 2.404M |
| September 30, 2016 | -4.126M |
| June 30, 2016 | -6.791M |
| March 31, 2016 | -3.601M |
| December 31, 2015 | -3.760M |
| September 30, 2015 | -5.005M |
| June 30, 2015 | -6.023M |
| March 31, 2015 | -4.889M |
| December 31, 2014 | 14.23M |
| September 30, 2014 | -2.343M |
| June 30, 2014 | -8.748M |
| March 31, 2014 | -6.273M |
| December 31, 2013 | 9.600M |
| September 30, 2013 | 0.097M |
| June 30, 2013 | -6.187M |
| March 31, 2013 | -3.540M |
| December 31, 2012 | 1.350M |
| September 30, 2012 | -4.656M |
| June 30, 2012 | -6.298M |
| March 31, 2012 | -4.790M |
| December 31, 2011 | -19.20M |
| September 30, 2011 | -3.309M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-23.00M
Minimum
Mar 2023
20.55M
Maximum
Jun 2020
6.802M
Average
4.92M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| uniQure NV | -51.58M |
| ProQR Therapeutics NV | -6.575M |
| Merus NV | -36.32M |
| argenx SE | -- |
| Pharvaris NV | -25.38M |